Pfizer Corporation (PFE)

In the latest trading session, Pfizer (NYSE: PFE) closed at $40.55, marking a -1.53% move from the previous day. This change lagged the S&P 500's 0.09% gain on the day. Meanwhile, the Dow lost 0.03%, and the Nasdaq, a tech-heavy index, lost 2.51%. Coming into today, shares of the drugmaker...

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Shares of Pfizer Inc. traded today at $51.76, eclipsing its 52-week high. This new high was reached on approximately average trading...

It’s been a dull week so far, but things pick up starting today in case you’re falling asleep. The main event comes this afternoon with minutes from the last Federal Open Market Committee (FOMC) meeting last month. The minutes are being looked at as something that could give the market...

A day after a lackluster session, stocks seem poised to bounce back as investors continue to be optimistic about a stimulus package from Washington and positive economic impact from the vaccine rollout. Treasury Secretary Janet Yellen added fuel to the stimulus hopes after yesterday’s closing...

This week is all about healthcare with Pfizer Inc. (NYSE: PFE), Sanofi SA (NASDAQ: SNY), Regeneron Pharmaceticals Inc (NASDAQ: REGN), and Bristol-Myers Squibb Co (NYSE: BMY) reporting earnings. But, what is under the spotlight is the effort pharmaceutical and biotech companies are making to combat...

Another busy week for traders and investors with earnings, economic data, central bank activity, and lot to keep an eye on. First, it was a busy week last week with something like 120 S&P 500 companies reporting quarterly, and U.S. indices to new all-time highs reflected the better-than-...

The groundhog is about to tell us how much longer winter might last. At the same time, events in February could give investors an idea how much longer COVID-19 might keep the economy’s emergency brake pressed to the floor. Will earnings and data begin to show more signs of recovery from the...

2020 was saved thanks to Pfizer Inc. (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA) whose vaccines against COVID-19 helped us see the light at the end of the pandemic tunnel. But unlike Pfizer with its rich long history in vaccines, Moderna became a household name only after its mRNA-1273...

Did you see the video footage over the weekend of those trucks leaving the Pfizer Inc. (NYSE: PFE) manufacturing plant in Michigan—the ones filled with the first shipments of the coronavirus vaccine it developed with BioNTech SE (NASDAQ: BNTX)? It seems many investors did...

What’s old is new again. Remember Brexit? Well, the market is reacting again to news about Britain’s divorce from the European Union, with the U.S. market following European shares lower on the possibility of the United Kingdom leaving the bloc this month without a trade agreement in...

If this morning is any indication, trading today could be a bit of a waiting game. As investors arrive at their desks—at home or in the office—it seems they’re looking for clarity on two big events that would likely move the market and affect the economy. One of those things is...

The waiting game that began last week continues, putting the long rally on pause. We’re an impatient lot, and when things aren’t happening quickly the market sometimes slumps, as we’ve seen so far this week.  The main thing investors are waiting for is any sign of Congress...

The big economic news this morning is the government’s latest jobs report, which came in below expectations. But before that came out, investors and traders seemed optimistic, as stimulus talks seem to be picking up steam in Washington.  That hope, enhanced by optimism about a vaccine,...